Short-term budget affordability of hepatitis C treatments for state Medicaid programs.

ABSTRACT:

Background

With some Medicaid state programs still restricting patient access to hepatitis C (HCV) treatment, it is important to demonstrate how states could expand treatment access to a broader Medicaid population and balance short-term budget concerns.

Methods

We used the HCV Transmission and Progression (TaP) Markov model to quantify the impact of removing restrictions to HCV treatment access on the infected populations, expenditures, and net social value for the North Carolina (NC), Oregon (OR), and Wisconsin (WI) Medicaid programs. Four HCV treatment access scenarios were modeled: 1) Baseline: Patients were treated according to Medicaid disease severity and sobriety requirements in 2015; 2) Remove Sobriety Restrictions: Disease severity restrictions were maintained, but

SUBMITTER: Chou JW 

PROVIDER: S-EPMC6394005 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature